Cargando…

MAGE‐A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer

BACKGROUND: MAGE‐A genes belong to the cancer/testis antigens family. The prognostic significance of MAGE‐A expression in the peripheral blood of patients with lung cancer is unknown. Therefore, this study evaluated the expression and possible prognostic significance of MAGE‐A in the peripheral bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Lina, Sang, Meixiang, Yin, Danjing, Liu, Fei, Wu, Yunyan, Liu, Shina, Huang, Weina, Shan, Baoen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879056/ https://www.ncbi.nlm.nih.gov/pubmed/29430849 http://dx.doi.org/10.1111/1759-7714.12571

Ejemplares similares

MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth
por: Liu, Shina, et al.
Publicado: (2017)

5-aza-2’-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells
por: Li, Zhenhua, et al.
Publicado: (2020)

Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
por: Zheng, Yang, et al.
Publicado: (2023)

Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins
por: Meng, Lingjiao, et al.
Publicado: (2018)

circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion
por: Gu, Lina, et al.
Publicado: (2022)

Correction: circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion
por: Gu, Lina, et al.
Publicado: (2023)

Identification of potential circular RNA biomarkers in lung adenocarcinoma: A bioinformatics analysis and retrospective clinical study
por: Zhu, Yonggang, et al.
Publicado: (2022)

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
por: Luo, Wen-Zhao, et al.
Publicado: (2023)

miR-92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2
por: Liu, Fei, et al.
Publicado: (2018)

MAGE genes: Prognostic indicators in AL amyloidosis patients
por: Liu, Yang, et al.
Publicado: (2019)

Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
por: Lian, Yishui, et al.
Publicado: (2018)

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer
por: Chen, Xinfeng, et al.
Publicado: (2017)

Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer
por: Liu, Jing-bo, et al.
Publicado: (2019)

The circRNA circADAMTS6 promotes progression of ESCC and correlates with prognosis
por: Bu, Jing, et al.
Publicado: (2022)

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
por: Go, Se-Il, et al.
Publicado: (2016)

The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma
por: GUO, LIRU, et al.
Publicado: (2013)

The emerging prospects of circular RNA in tumor immunity
por: Meng, Lingjiao, et al.
Publicado: (2020)

Activation of circ_0072088/miR‐1261/PIK3CA pathway accelerates lung adenocarcinoma progression
por: Cao, Feng, et al.
Publicado: (2022)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
por: Zhou, Yi, et al.
Publicado: (2014)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

SCUBE3 serves as an independent poor prognostic factor in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis
por: Li, Zhenhua, et al.
Publicado: (2019)

Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma
por: Arora, Mohit, et al.
Publicado: (2020)

Conditional transcriptional relationships may serve as cancer prognostic markers
por: Yu, Hui, et al.
Publicado: (2021)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

Cell cycle protein Bora serves as a novel poor prognostic factor in multiple adenocarcinomas
por: Zhang, Qiong-Xia, et al.
Publicado: (2017)

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
por: Go, Se-Il, et al.
Publicado: (2022)

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
por: Ozaki, Toshinori, et al.
Publicado: (2018)

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer
por: Wang, Feng-Jiao, et al.
Publicado: (2021)

The activity level of follicular helper T cells in the peripheral blood of osteosarcoma patients is associated with poor prognosis
por: Lu, Jianshu, et al.
Publicado: (2022)

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008)

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2022)

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation
por: Chen, Aaron, et al.
Publicado: (2020)

Prognostic roles of MAGE family members in breast cancer based on KM-Plotter Data
por: Jia, Binghan, et al.
Publicado: (2019)

Miltiwire proportional chambers MAGE spectrometer
por: Gusev, K E, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3e3b2vp175or4eb9eucs32spl7